Nephrocare Health Services IPO : All you Need to know
Nephrocare Health Services IPO Details
The Nephrocare Health Services IPO will open on 10 Dec 2025- 05 Dec 2025. The Total issue size of IPO is ₹871.05 cr. which includes a Fresh Issue and OFS (Offer for sale).
- IPO Price Band: ₹438-₹460 Per Share
- Lot Size: 32 shares
- Minimum Investment (Retail): ₹14,016 – ₹14,720/-
- Allotment Date: 15 Dec 2025
- Listing Date: 17 Dec 2025 on NSE and BSE
| Details | Information |
| IPO Open Date | 10 Dec 2025 |
| IPO Close Date | 12 Dec 2025 |
| Price Band | ₹438-₹460 Per Share |
| Lot Size | 32 shares |
| Minimum Investment | ₹14,016 – ₹14,720/- |
| Issue Size | ₹871.05 cr. |
| Allotment Date | 15 Dec 2025 |
| Listing Date | 17 Dec 2025 on NSE and BSE |
| Nephrocare Health Services IPO GMP | – |
Nephrocare Health Services IPO Issue Size
The Nephrocare Health Services Ltd. IPO will open for subscription on 10 December 2025 to 12 December 2025. The Company wiill planning to raise ₹871.05 cr through this public issue.
- Fresh Issue: ₹353.40 cr (76,82,717 shares) funds raised here will go directly into the company for expansion, debt repayment, and working capital needs.
- Offer For Sale: ₹517.64 cr. (1,12,53,102 shares ) existing shareholders will sell part of their stake, but the proceeds will not go to the company.,
Nephrocare Health Services IPO Issue Objective
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Capital expenditure by the Company for opening new dialysis clinics in India | 129.11 |
| 2 | Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company | 136.00 |
| 3 | General corporate purposes |
Nephrocare Health Services IPO Lot Size
Investors can apply for the IPO in lots. The Nephrocare Health Services IPO Lot Size is fixed at 32 shares per lot.
Below is the table showing lot size details for Retail Investors and **HNIs (High Net Worth Individuals):
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 32 | ₹14,720 |
| Retail (Max) | 13 | 416 | ₹1,91,360 |
| S-HNI (Min) | 14 | 448 | ₹2,06,080 |
| S-HNI (Max) | 67 | 2,144 | ₹9,86,240 |
| B-HNI (Min) | 68 | 2,176 | ₹10,00,960 |
Nephrocare Health Services Ltd. IPO Prospectus
Nephrocare Health Services DRHP
Nephrocare Health Services Ltd. IPO Reservation
The IPO shares are divided among different investor categories. Here is the Nephrocare Health Services IPO reservatimon (quota) details:
| Investor Category | Reservation % |
| QIB (Qualified Institutional Buyers) | 50% of the issue |
| NII / HNI (Non-Institutional Investors) | 15% of the issue |
| Retail Investors | 35% of the issue |
How to Apply for Nephrocare Health Services Ltd. IPO
Applying for the Nephrocare Health Services IPO is simple. You can apply through your demat account, net banking (ASBA), or brokerage app like Zerodha, Upstox, Groww, Angel One, ICICI Direct, etc.
Step-by-Step Guide
- Login to Your Demat Account
- Open your broker app (like Zerodha, Groww, Upstox) or net banking (like HDFC, ICICI, SBI).
- Go to IPO Section
- Look for the “IPO” tab or “Current Issues” option.
- Select
- Click on Nephrocare Health Services Ltd. IPO Apply option.
- Choose Your Category & Lot Size
- Retail Investor: Minimum 1 lot = 32 shares.
- HNI (sHNI/bHNI): Higher multiples (check the Nephrocare Health Services IPO lot size table above).
- Enter Bid Price
- You can bid at the cut-off price (safest option) or enter a price within the band ₹438 – ₹460
- Confirm & Submit
- Enter your UPI ID (if using UPI) and approve the mandate on your UPI app.
- For ASBA (net banking), the amount will be a blocked in your bank account.
- IPO closes on 12 December 2025.
- Allotment date: 15 December 2025.
- Check status on kFin Technologies Limited
Nephrocare Health Services Ltd. Promotors Holding
- Vikram Vuppala
- Bessemer Venture Partners Trust
- Edoras Investment Holdings Pte. Ltd
- Healthcare Parent Limited
- Investcorp Private Equity Fund II
- Investcorp Growth Opportunity Fund
| Description | Percentage (%) |
| Promoter Holding Pre-Issue | 78.90% |
| Promoter Holding Post-Issue | 71.49% |
Understanding IPO Lot Size, Price Band, and Allotment Process
What is IPO? A Beginner’s Guide to Initial Public Offerings in brief
Gold ETF vs Physical Gold – Which is the Smarter Investment?
Key Performance Indicators for Nephrocare Health Services Ltd. IPO
| KPI | Value |
| Return on Capital Employed (ROCE) | 18.67% |
| EBITDA Margin | 22.05% |
| Price to Earning (P/E) Pre IPO | 63.52 |
| Return on Net Worth (RoNW) | 13.19% |
| PAT Margin (%) | 8.88% |
| Return On Equity (ROE) | 13.45% |
| Debt/Equity | |
| Price to Book Value (P/BV) | 7.72 |
Nephrocare Health Services Ltd. IPO Registrar and Lead Managers
Nephrocare Health Services IPO Lead Managers.
- ICICI Securities Limited/nAmbit Pvt.Ltd
IIFL Capital Services Ltd.
Nomura Financial Advisory & Securities (India) Pvt.Ltd.
Nephrocare Health Services IPO Registrar
Kfin Technologies Ltd
04067162222, 04079611000
nephrocare.ipo@kfintech.com
https://ipostatus.kfintech.com
Nephrocare Health Services Financials (In Crs)
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 1,193.68 | 996.46 | 806.02 | 666.23 |
| Total Income | 483.97 | 769.92 | 574.72 | 443.26 |
| Profit After Tax | 14.23 | 67.10 | 35.13 | -11.79 |
| EBITDA | 110.31 | 166.64 | 99.66 | 48.60 |
| NET Worth | 716.06 | 594.21 | 423.55 | 384.73 |
| Reserve and Surplus | 704.14 | 578.68 | 408.57 | 383.50 |
| Total Borrowing | 207.04 | 225.80 | 243.37 | 196.21 |
About Nephrocare Health Services Company
Incorporated in December 2009.Nephrocare Health Services is a dialysis-services company based in Hyderabad, India.
The company provides comprehensive renal (kidney) care, especially dialysis. Its services include: in-clinic haemodialysis, home dialysis, mobile dialysis (dialysis-on-wheels), holiday dialysis, “dialysis-on-call,” and pharmacy support.
They operate under a variety of formats: standalone clinics, clinics inside hospitals (captive clinics), public-private partnerships (PPPs), and a mixture of greenfield (new) and brownfield (existing facility conversion) clinics.
For quality and standardization, they follow protocol-led dialysis practices via their proprietary protocols (e.g. “RenAssure” across clinics).
Nephrocare Health Services
5th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad, Telangana, 500081
+91 40 4240 8039
Stay Ahead with Busyshell.com
DISCLAIMER
The information provided on this website is strictly for educational and informational purposes only. We do not recommend any specific investments.
All content, including but not limited to articles, analysis, market updates, IPO information, stock recommendations, and financial data, should not be construed as personalized investment advice or solicitation to buy or sell any securities.
We are not SEBI registered advisors. This content is for informational and educational purposes only and should not be considered as investment advice.